Indeed, downregulation of PPARD reduced vitamin D receptor (VDR) expression and subsequently mitigated its inhibitory effect on the SOX2 promoter, thus promoting SOX2 expression and resulting in tumor growth and drug resistance of colorectal CSCs [156]. The gene discussed is PPARD; the disease is neoplasm.